Zobrazeno 1 - 10
of 24
pro vyhledávání: '"M N, Ozeretskovskaia"'
Autor:
E M, Zaĭtsev, N Iu, Mertsalova, M V, Britsina, M N, Ozeretskovskaia, I G, Bazhanova, A S, Shinkarev, A V, Poddubikov
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (4)
Study specific activity and safety ofvaccine preparations based on circulating B. pertussis strains with currently predominating allele variants of pertussis toxin (ptxA1) and pertactin (prn2) genes.B. pertussis strains isolated from pertussis patien
Autor:
E M, Zaĭtsev, A V, Poddubikov, M V, Britsina, N U, Mertsalova, M N, Ozeretskovskaia, I G, Bazhanova, N G, Plekhanova
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (1)
Study of Bordetella pertussis lipopolysaccharide (LPS) immunobiological properties in the acellular pertussis vaccine.Experimental series of acellular pertussis vaccines (APV), lyophilized LPS were used. Antibody titers against LPS in mice sera were
Autor:
E M, Zaĭtsev, M V, Britsina, I G, Bazhanova, N U, Mertsalova, M N, Ozeretskovskaia, E V, Ermolova, N G, Plekhanova, N A, Mikhaĭlova, V A, Kolyshkin, V V, Zverev
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (6)
Evaluate standardness of antigenic composition of pertussis component, completeness of sorption of pertussis, diphtheria and tetanus components, specific activity and safety of experimental series ofADTP-vaccine with acellular pertussis component (AD
Autor:
N V, Tyshko, M V, Britsina, I V, Gmoshinskiĭ, N S, Zakharova, S N, Zorin, V K, Mazo, M N, Ozeretskovskaia, K E, Seliaskin
Publikováno v:
Voprosy pitaniia. 79(3)
There are presented the results of genotoxicologic, immunologic and allergologic examinations which were conducted within the framework of integrated medical and biological assessment of genetically modified second generation soybean event MON 89788.
Autor:
N U, Mertsalova, O Iu, Borisova, A S, Shinkarev, M V, Britsina, M N, Ozeretskovskaia, I K, Mazurova, V A, Aleshkin, N T, Gadua, N S, Zakharova
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (6)
To study pathogenic characteristics of B. pertussis strains isolated from patients during different periods of pertussis infection epidemic process.Strains of B. pertussis isolated in Moscow during 1967 - 1971, 1980 - 1985, and 2001 - 2005 were studi
Autor:
E M, Zaĭtsev, A V, Poddubikov, M V, Britsina, N U, Mertsalova, I G, Bazhanova, M N, Ozeretskovskaia, M P, Nazirov, I K, Mazurova, M S, Petrova, O P, Popova, N S, Zakharova
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (6)
To assess antigenic composition consistency and serological characteristics of domestic acellular pertussis vaccine.Amount of pertussis toxin, filamentous hemagglutinin, agglutinogens types 1, 2, and 3 in experimental batches of vaccine was measured
Autor:
N V, Tyshko, M V, Britsina, I V, Gmoshinskiĭ, A K, Zhanataev, N S, Zakharova, S N, Zorin, V K, Mazo, M N, Ozeretskovskaia, B F, Semenov
Publikováno v:
Voprosy pitaniia. 78(2)
There are presented the results of genotoxicologic, immunologic and allergologic examinations which were conducted within the framework of integrated medical and biological assessment of genetically modified rootworm Diabrotica spp.-protected maize e
Autor:
N S, Zakharova, M V, Britsina, N U, Mertsalova, I G, Bazhanova, M N, Ozeretskovskaia, E M, Zaĭtsev, A V, Poddubikov, B F, Semenov
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (1)
Protective, immunogenic, toxic, and sensitizing properties of acellular pertussis vaccine (aPV) developed according to original technology were studied, aPV had marked protective activity which lasted more than 2 years. Sera of mice immunized by aPV
Autor:
N S, Zakharova, M V, Britsina, M N, Ozeretskovskaia, I G, Bazhanova, N U, Mertsalova, A V, Poddubikov, E M, Zaĭtsev, E V, Ermolova
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (2)
The introduction of the immunomodulator polyoxidonium in an amount of 0.5 Mg/ml into adsorbed D(a)PT vaccine with the acellular pertussis component leads to the preservation of the protective activity of the pertusis component, diphtheria and tetanus
Autor:
B F, Semenov, N S, Zakharova, M V, Britsina, N U, Mertsalova, M N, Ozeretskovskaia, T I, Valiakina, R L, Komaleva, T M, Andronova, V A, Nesmeianov
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (6)
As shown in this work, the synthetic immunomodulator glucosaminylmuramyldipeptide (GMDP) can be included into acellular pertussis vaccine (APV). The optimal doses of GMDP, ranging from 0.001 to 0.0001 microg, have been found. These doses enhance the